Michael Lopez

Michael Lopez, PhD is an Assistant Professor in the Department of Neurology at the University of California, Irvine School of Medicine. His research focuses on the molecular mechanisms underlying neuromuscular disorders, particularly related to DOCK3 protein function and skeletal muscle biology.

Dr. Lopez's research interests include:

• Muscular Dystrophy pathophysiology and potential therapeutic targets
• DOCK3 protein function in cell migration, fusion, and viability
• Skeletal muscle regeneration and glucose metabolism
• Neurodevelopmental disorders associated with DOCK family proteins
• Molecular genetics of neuromuscular diseases
• miR-486/DOCK3 signaling cascade in dystrophin-deficient muscle

Analysis of Dr. Lopez's publication record reveals a strong focus on the nuanced role of DOCK3 in muscle health - where partial reduction improves dystrophic symptoms while complete loss worsens muscle function. His work spans from basic molecular mechanisms to potential therapeutic applications, with significant contributions to understanding the connection between skeletal muscle function and neurological outcomes. Key research areas include myoblast fusion mechanisms, muscle regeneration pathways, and the therapeutic potential of targeting the miR-486/DOCK3 axis in muscular dystrophy.

Dr. Lopez has received research support from multiple NIH grants including R01 HD095897, R21 AR074006, and F99 NS118718, indicating strong institutional support for his research program in neuromuscular disorders and developmental biology.